Wright Medical Group NV (Wright Medical Group NV) Cash, Cash Equivalents, Marketable Securities : $141.5 Mil (As of Sep. 2020)

View and export this data going back to 2011. Start your Free Trial

What is Wright Medical Group NV Cash, Cash Equivalents, Marketable Securities?

Wright Medical Group NV's quarterly cash, cash equivalents, marketable securities increased from Mar. 2020 ($102.84 Mil) to Jun. 2020 ($133.65 Mil) and increased from Jun. 2020 ($133.65 Mil) to Sep. 2020 ($141.55 Mil).

Wright Medical Group NV's annual cash, cash equivalents, marketable securities increased from Dec. 2017 ($167.74 Mil) to Dec. 2018 ($191.35 Mil) but then declined from Dec. 2018 ($191.35 Mil) to Dec. 2019 ($166.86 Mil).

Wright Medical Group NV Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Wright Medical Group NV's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wright Medical Group NV Cash, Cash Equivalents, Marketable Securities Chart

Wright Medical Group NV Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Cash, Cash Equivalents, Marketable Securities

Get a 7-Day Free Trial

139.80

262.27

167.74

191.35

166.86

Wright Medical Group NV Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial															147.26	166.86	102.84	133.65	141.55

Wright Medical Group NV Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Wright Medical Group NV (NAS:WMGI) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Wright Medical Group NV Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Wright Medical Group NV's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Wright Medical Group NV (Wright Medical Group NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wright Medical Group NV (NAS:WMGI) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Prins Bernhardplein 200, Amsterdam, NLD, 1097 JB

Website

http://www.wright.com

Wright Medical Group develops medical devices and products in five categories: lower extremities, upper extremities, biologics, large joints, and sports medicine, and other. Products for lower extremities include joint implants and bone fixation devices for the foot and ankle, whereas products for upper extremities include implants and devices for the shoulder, elbow, wrist, and hand. The biologics business sells products used to treat damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The large joints business sells hip and knee replacement implants. The firm's sports medicine products are used to mechanically repair tissue injuries. Wright Medical Group generates the majority of its revenue in the United States.

Executives

Steven P. Wallace	officer: President, International	1023 CHERRY ROAD MEMPHIS TN 38117
Barry J. Regan	officer: SVP, Operations	1023 CHERRY ROAD, MEMPHIS TN 38117
Kevin C. Smith	officer: SVP, Quality and Regulatory	1023 CHERRY ROAD MEMPHIS TN 38117
Jason D. Asper	officer: SVP, Chief Digital Officer	1023 CHERRY ROAD MEMPHIS TN 38117
Tim Lanier	officer: President, Upper Extremities	1023 CHERRY ROAD MEMPHIS TN 38117
Patrick Fisher	officer: President, Lower Extremities	1023 CHERRY ROAD MEMPHIS TN 38117
Jonathan Wesley Porter	officer: SVP, Chief Compliance Officer	1023 CHERRY ROAD MEMPHIS TN 38117
Julie Andrews	officer: SVP, Global Finance	5677 AIRLINE ROAD, ARLINGTON TN 38002
Jennifer S. Walker	officer: SVP, Process Improvement	5677 AIRLINE ROAD ARLINGTON TN 38002
Andrew C. Morton	officer: SVP, Chief Human Resources Ofr	10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Lance A Berry	officer: EVP, Chief Finan./Op. Officer	5677 AIRLINE ROAD, ARLINGTON TN 38002
Julie D. Dewey	officer: SVP, Chief Comm. Officer	1023 CHERRY ROAD MEMPHIS TN 38117
Kevin D Cordell	officer: EVP, Chief Global Comm Officer	C/O WRIGHT MEDICAL GROUP, INC. 1023 CHERRY ROAD MEMPHIS TN 38117
Robert J Palmisano	director, officer: President and Chief Executive	110 HARTWELL AVENUE, LEXINGTON MA 02173
Peter Cooke	officer: Pres. Emerging Markets AUS/JAP	5677 AIRLINE ROAD ARLINGTON TN 38002